How Gender and Victim Blame Impact the Identification of Human Trafficking Victims

Human trafficking is a worldwide phenomenon that uses fraud, force, or coercion to subjugate human beings into a modern form of slavery. Male and transgender victims have been excluded from previous research and as a result, the numbers of victims identifying as male, and transgender is unknown. This study examined the impact of gender and victim blame on the identification of human trafficking victims, particularly male and transgender. The theoretical frameworks of feminist theory and belief in a just world theory supported the study and supported the hypotheses. The research questions focused on the impact of gender and victim blame as it pertained to male and transgender human trafficking victims. The study was a quantitative study with a cross-sectional design, that used the Modified Victim Blaming Measure. A pilot study was conducted within the full study to determine the validity of the measure. There were 450 participants who completed the measure and an ANOVA and MANOVA was used to analyze the data from the vignette questions to determine any significance. The findings of the analysis revealed that gender and the trafficking situation both significantly impact victim blame attributed to human trafficking victims. The analysis also found that the identification of the victims was impacted by the trafficking situation suggesting that victims are less likely to be identified. This study helps support social change through the inclusion of all victims of human trafficking and by providing more information on the impact that gender and victim blame have on these victims

Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest.

The emergence of Cryptococcus gattii, previously regarded as a predominantly tropical pathogen, in the temperate climate of the North American Pacific Northwest (PNW) in 1999 prompted several questions. The most prevalent among these was the timing of the introduction of this pathogen to this novel environment. Here, we infer tip-dated timing estimates for the three clonal C. gattii populations observed in the PNW, VGIIa, VGIIb, and VGIIc, based on whole-genome sequencing of 134 C. gattii isolates and using Bayesian evolutionary analysis by sampling trees (BEAST). We estimated the nucleotide substitution rate for each lineage (1.59 × 10-8, 1.59 × 10-8, and 2.70 × 10-8, respectively) to be an order of magnitude higher than common neutral fungal mutation rates (2.0 × 10-9), indicating a microevolutionary rate (e.g., successive clonal generations in a laboratory) in comparison to a species' slower, macroevolutionary rate (e.g., when using fossil records). The clonal nature of the PNW C. gattii emergence over a narrow number of years would therefore possibly explain our higher mutation rates. Our results suggest that the mean time to most recent common ancestor for all three sublineages occurred within the last 60 to 100 years. While the cause of C. gattii dispersal to the PNW is still unclear, our research estimates that the arrival is neither ancient nor very recent (i.e., <25 years ago), making a strong case for an anthropogenic introduction. IMPORTANCE The recent emergence of the pathogenic fungus Cryptococcus gattii in the Pacific Northwest (PNW) resulted in numerous investigations into the epidemiological and enzootic impacts, as well as multiple genomic explorations of the three primary molecular subtypes of the fungus that were discovered. These studies lead to the general conclusion that the subtypes identified likely emerged out of Brazil. Here, we conducted genomic dating analyses to determine the ages of the various lineages seen in the PNW and propose hypothetical causes for the dispersal events. Bayesian evolutionary analysis strongly suggests that these independent fungal populations in the PNW are all 60 to 100 years old, providing a timing that is subsequent to the opening of the Panama Canal, which allowed for more direct shipping between Brazil and the western North American coastline, a possible driving event for these fungal translocation events

Framing the Issues: Moral Distress in Health Care

Moral distress in health care has been identified as a growing concern and a focus of research in nursing and health care for almost three decades. Researchers and theorists have argued that moral distress has both short and long-term consequences. Moral distress has implications for satisfaction, recruitment and retention of health care providers and implications for the delivery of safe and competent quality patient care. In over a decade of research on ethical practice, registered nurses and other health care practitioners have repeatedly identified moral distress as a concern and called for action. However, research and action on moral distress has been constrained by lack of conceptual clarity and theoretical confusion as to the meaning and underpinnings of moral distress. To further examine these issues and foster action on moral distress, three members of the University of Victoria/University of British Columbia (UVIC/UVIC) nursing ethics research team initiated the development and delivery of a multi-faceted and interdisciplinary symposium on Moral Distress with international experts, researchers, and practitioners. The goal of the symposium was to develop an agenda for action on moral distress in health care. We sought to develop a plan of action that would encompass recommendations for education, practice, research and policy. The papers in this special issue of HEC Forum arose from that symposium. In this first paper, we provide an introduction to moral distress; make explicit some of the challenges associated with theoretical and conceptual constructions of moral distress; and discuss the barriers to the development of research, education, and policy that could, if addressed, foster action on moral distress in health care practice. The following three papers were written by key international experts on moral distress, who explore in-depth the issues in three arenas: education, practice, research. In the fifth and last paper in the series, we highlight key insights from the symposium and the papers in the series, propose to redefine moral distress, and outline directions for an agenda for action on moral distress in health care

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

BACKGROUND. Monogenic IFN-mediated autoinflammatory diseases present in infancy with systemic inflammation, an IFN response gene signature, inflammatory organ damage, and high mortality. We used the JAK inhibitor baricitinib, with IFN-blocking activity in vitro, to ameliorate disease. METHODS. Between October 2011 and February 2017, 10 patients with CANDLE (chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures), 4 patients with SAVI (stimulator of IFN genes-associated [STING-associated] vasculopathy with onset in infancy), and 4 patients with other interferonopathies were enrolled in an expanded access program. The patients underwent dose escalation, and the benefit was assessed by reductions in daily disease symptoms and corticosteroid requirement. Quality of life, organ inflammation, changes in IFN-induced biomarkers, and safety were longitudinally assessed. RESULTS. Eighteen patients were treated for a mean duration of 3.0 years (1.5-4.9 years). The median daily symptom score decreased from 1.3 (interquartile range [IQR], 0.93-1.78) to 0.25 (IQR, 0.1-0.63) (P < 0.0001). In 14 patients receiving corticosteroids at baseline, daily prednisone doses decreased from 0.44 mg/kg/day (IQR, 0.31-1.09) to 0.11 mg/kg/day (IQR, 0.02-0.24) (P < 0.01), and 5 of 10 patients with CANDLE achieved lasting clinical remission. The patients' quality of life and height and bone mineral density Z-scores significantly improved, and their IFN biomarkers decreased. Three patients, two of whom had genetically undefined conditions, discontinued treatment because of lack of efficacy, and one CANDLE patient discontinued treatment because of BK viremia and azotemia. The most common adverse events were upper respiratory infections, gastroenteritis, and BK viruria and viremia. CONCLUSION. Upon baricitinib treatment, clinical manifestations and inflammatory and IFN biomarkers improved in patients with the monogenic interferonopathies CANDLE, SAVI, and other interferonopathies. Monitoring safety and efficacy is important in benefit-risk assessment

The fractured Moon: Production and saturation of porosity in the lunar highlands from impact cratering

We have analyzed the Bouguer anomaly (BA) of ~1200 complex craters in the lunar highlands from Gravity Recovery and Interior Laboratory observations. The BA of these craters is generally negative, though positive BA values are observed, particularly for smaller craters. Crater BA values scale inversely with crater diameter, quantifying how larger impacts produce more extensive fracturing and dilatant bulking. The Bouguer anomaly of craters larger than urn:x-wiley:00948276:media:grl53324:grl53324-math-0001 km in diameter is independent of crater size, indicating that there is a limiting depth to impact‐generated porosity, presumably from pore collapse associated with either overburden pressure or viscous flow. Impact‐generated porosity of the bulk lunar crust is likely in a state of equilibrium for craters smaller than ~30 km in diameter, consistent with an ~8 km thick lunar megaregolith, whereas the gravity signature of larger craters is still preserved and provides new insight into the cratering record of even the oldest lunar surfaces

How do early parenting centres support women with an infant who has a sleep problem?

Some women who have an infant experiencing sleep problems are so sleep deprived themselves that admission to an early parenting centre is needed to help them better manage the situation. This paper reports on a qualitative study that used focus group methods to interview familes who were admitted to an early parenting centre for persistent infant sleep problems. Results showed that parents needed a variety of strategies such as instructional, emotional and physical supports to develop confidence to manage infant\u27s sleep disturbance at home.<br /

Workshop 1: Accessing Data on Children and Families: Mississippi KIDS COUNT

When it comes to the economic, educational and health status of children, families and communities, have you ever wondered if what you are seeing and hearing anecdotally in your work is substantiated by data? Have you wondered how your county compares to others across the state? How your state compares to others across the nation? Do you often wish you had data to support your proposals, reports, and policy recommendations? This workshop will acquaint you with the work of Mississippi KIDS COUNT and show you how to access and incorporate data about children and families into your work